Center-Authored Papers

Filters: Author is Jänne, Pasi A  [Clear All Filters]
2017
Peters S, Gettinger S, Johnson ML, Jänne PA, Garassino MC, Christoph D, Toh CK, Rizvi NA, Chaft JE, Carcereny Costa E et al..  2017.  Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. :JCO2016719476. Abstract
2016
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
2014
Jänne PA, Ou S-HI, Kim D-W, Oxnard GR, Martins R, Kris MG, Dunphy F, Nishio M, O'Connell J, Paweletz C et al..  2014.  Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.. The Lancet. Oncology. 15(13):1433-41. Abstract